July 19th thru July 30th, 2021
Price: $75 (APPs, GCs, MD trainees), $150 (practicing physicians), or $250 (corporate)
Offered again Nov 1-12, 2021 (registration opens Sept 1, 2021)
Approved for 4.0 AMA PRA Category. 1 Credits™/ 4.0 AAPA Category 1 CME credits/ 4.0 ANCC Contact Hours/4.0 Credits for Dieticians
HOMOCYSTEINEMIAS ONLINE SHORT COURSE
This online short course is spread out over two weeks to accommodate a full-time working schedule. It includes a mix of learning experiences - six short live sessions (with a choice of 9:00am or 5:00pm ET), brief pre-recorded video seminars to review when convenient, and homework exercises. The curriculum also includes a live patient presentation and a special session addressing the role of the non-physician in patient diagnosis/management. The duration of the course allows a comprehensive review of the topic and the opportunity to apply the learned principles to several clinical situations.
The course targets primarily (but not exclusively) advanced practice providers and clinicians who:
Nurses/nurse practitioners, physician assistants, genetic counselors, and dietitians, and their trainees, are especially welcome, but physician, research, and corporate applicants are invited to participate as well.
At the end of each training, attendees should be able to:
Each course is spaced out over two weeks with six live sessions to support working schedules and enhance recall. Once you register for either the 9am or 5pm (ET) track you will be provided login information to access a restricted webpage that will house all the documents, links, videos and material for the course.
Monday (<30 min remote session, choice of 9:00am or 5:00pm ET)
Wednesday (30-40 min remote session, choice of 9:00am or 5:00pm ET)
Friday (30-40 min remote session, choice of 9:00am or 5:00pm ET)
Monday (60 min remote session, choice of 9:00am or 5:00pm ET)
Wednesday (45 min remote session, choice of 9:00am or 5:00pm ET)
Friday (45 min remote session, choice of 9:00am or 5:00pm ET)
A syllabus will be provided to all participants.
VMP's EDUCATION PHILOSOPHY
Continuing Education Credits:
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Virtual Medical Practice. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education The Postgraduate Institute for Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is 4.0 contact hours.
AAPA Credit Designation Statement
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Dietician Education This program offers 4.0 CPEUs for dieticians.
Computer System Requirements:
Zoom & Youtube account with access to DSL 15 Mbps or higher, Fiber, 4g, or 5g internet access. The higher the Mbps, the better the quality.
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
DIsclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Jointly provided by Postgraduate Institute for Medicine and Virtual Medical Practice.
This activity is supported by an independent educational grant from Recordati Rare Diseases.
....when enrolling, please let us know if you will be attending the 9am or 5pm (ET) course